Cystatin C Protein (Cst3) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
This page provides comprehensive information about Cystatin C Protein, including its structure, normal function in the nervous system, and its role in neurodegenerative diseases.
:: infobox infobox-protein !Protein Name | Cystatin C (CST3) !Gene | [CST3](/proteins/cst3-protein) !UniProt ID | [P01034](https://www.uniprot.org/uniprot/P01034) !PDB Structure | 1G96, 3GAX, 4JFL !Molecular Weight | ~13 kDa (monomer) !Subcellular Localization | Extracellular, secreted !Protein Family | Cystatin family (type 2) !
Structure
Cystatin C is a secreted cysteine protease inhibitor with a characteristic cystatin fold:
Cystatin C Protein (Cst3) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
This page provides comprehensive information about Cystatin C Protein, including its structure, normal function in the nervous system, and its role in neurodegenerative diseases.
:: infobox infobox-protein !Protein Name | Cystatin C (CST3) !Gene | [CST3](/proteins/cst3-protein) !UniProt ID | [P01034](https://www.uniprot.org/uniprot/P01034) !PDB Structure | 1G96, 3GAX, 4JFL !Molecular Weight | ~13 kDa (monomer) !Subcellular Localization | Extracellular, secreted !Protein Family | Cystatin family (type 2) !
Structure
Cystatin C is a secreted cysteine protease inhibitor with a characteristic cystatin fold:
Signal peptide (aa 1-26): Directs secretion via the classical secretory pathway
N-terminal region (aa 27-53): Contains the "cystatin domain 1" with protease binding site
Central region (aa 54-102): Forms a beta-hairpin "stiff loop" that interacts with protease active sites
C-terminal region (aa 103-146): Completes the cystatin fold
The protein forms a dimer at physiological concentrations, and dimerization is enhanced in the amyloidogenic L68Q variant.
Normal Function
Cystatin C has several important physiological functions:
Protease Inhibition: The primary function is inhibition of cathepsins B, H, L, and S, regulating extracellular matrix remodeling and protein turnover.
Antimicrobial Defense: Secreted cystatin C provides innate immunity against microbial invasion.
Cell Proliferation and Differentiation: CST3 modulates cell growth and differentiation through cathepsin inhibition.
Brain Function: In the CNS, cystatin C is produced by [neurons](/entities/neurons) and glia and regulates synaptic plasticity and memory formation.
Role in Disease
Cerebral Amyloid Angiopathy (CST3-APP/Icelandic)
The CST3 L68Q mutation (also called the "Icelandic mutation") causes autosomal dominant cerebral amyloid angiopathy:
Amyloid Deposition: Mutant cystatin C forms amyloid deposits in cerebral blood vessel walls
Hemorrhage: Leads to lobar intracerebral hemorrhages, typically in elderly patients
Prevalence: The L68Q mutation is particularly common in Icelandic families (1 in 4,000 carriers)
Mechanism: The mutation promotes dimerization and amyloid fibril formation
Alzheimer's Disease
Cystatin C has complex relationships with AD:
Protective Effects: CST3 expression is increased in AD brain, potentially as a protective response to [Aβ](/proteins/amyloid-beta) deposition
[Aβ](/proteins/amyloid-beta) Binding: Cystatin C can bind to Aβ and inhibit its aggregation
Therapeutic Potential: Recombinant cystatin C is being explored as a neuroprotective agent
Parkinson's Disease
Lewy Bodies: Cystatin C is found in Lewy bodies in some PD patients
Neuroprotection: May have protective effects against [α-synuclein](/proteins/alpha-synuclein) aggregation
Therapeutic Targeting
Key Publications
Ghiso J, et al. (1986) "The cerebral amyloid angiopathy (CAA) in Iceland." Acta Med Scand 215:255-262.
Kaeser SA, et al. (2007) "Cystatin C modulates beta-amyloid aggregation." Neurobiol Aging 28:1023-1032. [DOI:10.1016/j.neurobiolaging.2006.05.025](https://doi.org/10.1016/j.neurobiolaging.2006.05.025)
Skerget K, et al. (2020) "Cystatin C and its role in neurodegenerative diseases." Int J Mol Sci 21:8974. [DOI:10.3390/ijms21238974](https://doi.org/10.3390/ijms21238974)
Benussi L, et al. (2021) "Cystatin C: A promising biomarker for Alzheimer's disease." J Prev Alzheimers Dis 8:324-333.
Background
The study of Cystatin C Protein (Cst3) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.